Intrum: Strong RoR In 5 Months, Upside Materializing

Intrum (ITJTQ/INJJQ) is reportedly making significant progress in its turnaround, evidenced by strong Q1 2025 results, improved profitability, and an ongoing successful recapitalization. Strategic partnerships, notably with Cerberus, are positioning the company for sustainable, capital-light growth. An analyst maintains high conviction, projecting 100-150% return potential with a fair value target of 140-200 SEK, recommending a 'buy' below 140 SEK, despite acknowledging execution risks and a potential dividend resumption only post-deleveraging by 2027.

Analysis

Intrum's (ITJTQ) turnaround is reportedly advancing, supported by strong Q1 2025 financial results and improving profitability. A successful recapitalization effort is underway, complemented by a strategic partnership with Cerberus, which is designed to transition Intrum to a more sustainable, capital-light business model. Despite a recent share price rally of over 130% since February 2025, the analyst maintains high conviction, projecting an additional 100-150% return potential. This outlook is supported by a fair value target of 140-200 SEK and a specific 'buy' recommendation for the stock below 140 SEK. Key risks to this thesis remain centered on execution and the pace of the earnings recovery. The timeline for a full normalization is projected for 2027, with the resumption of dividends considered unlikely until the company's deleveraging process is complete.

Key Decisions for Investors

• Given the strong Q1 results and ongoing recapitalization, investors with a high risk tolerance could consider the analyst's 'buy' thesis, particularly at entry points below the 140 SEK level.
• Investors should closely monitor the company's execution on its turnaround strategy and the pace of earnings recovery, as these are identified as the primary risks to the investment case.
• A long-term investment horizon is essential, as a full recovery is not expected until 2027 and dividend resumption is contingent upon the completion of deleveraging, making this a capital appreciation play rather than a near-term income investment.